Skip to main content
Clinical Trials/ISRCTN93709209
ISRCTN93709209
Completed
Not Applicable

Therapy-efficacy of automatic positive airways pressure therapy with A-Flex compared to standard automatic positive airways pressure therapy in obstructive sleep apnoea (OSA) patients

Respironics International Inc. (France)0 sites40 target enrollmentMay 15, 2008

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Obstructive sleep apnoea
Sponsor
Respironics International Inc. (France)
Enrollment
40
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 15, 2008
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Respironics International Inc. (France)

Eligibility Criteria

Inclusion Criteria

  • 1\. Apnoea\-Hypopnoea Index (AHI) greater than 15/h confirmed by full polysomnograph (PSG)
  • 2\. Aged greater than or equal to 21 to less than or equal to 65 years, either sex
  • 3\. Body mass index (BMI) less than 40 kg/m^2
  • 4\. Able to follow the study protocol

Exclusion Criteria

  • 1\. Acute upper respiratory infection, encephalitis, sinusitis or middle ear infection
  • 2\. Drug abuse
  • 3\. Intake of central relevant drugs, sedatives, or other drugs which impair sleep
  • 4\. Alcohol abuse
  • 5\. Psychiatric or neurological diseases resulting in impairment of sleep, therapy or compliance
  • 6\. Thyroidal dysfunction
  • 7\. Chronic pain syndromes
  • 8\. Acute cardiac, pulmonary, and other internal diseases
  • 9\. Chronic cardiac, pulmonary and other internal diseases resulting in impairment of sleep
  • 10\. Central sleep related breathing disorders or other disorders resulting in hypoventilation

Outcomes

Primary Outcomes

Not specified

Similar Trials